|
US4777964A
(en)
|
1986-01-02 |
1988-10-18 |
David Briggs |
System for obtaining blood samples and submitting for testing of aids
|
|
US5223440A
(en)
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
|
US5096830A
(en)
|
1987-11-17 |
1992-03-17 |
Adeza Biomedical Corporation |
Preterm labor and membrane rupture test
|
|
US4919889A
(en)
|
1988-09-15 |
1990-04-24 |
Aspen Diagnostics Corporation |
Sample collection and transport fluid composition
|
|
US5281522A
(en)
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
|
DE69231636T2
(de)
|
1991-11-04 |
2001-05-23 |
Adeza Biomedical Corp |
Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko
|
|
WO1993009432A1
(en)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5516702A
(en)
|
1991-11-06 |
1996-05-14 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5898005A
(en)
|
1993-02-24 |
1999-04-27 |
Dade Behring Inc. |
Rapid detection of analytes with receptors immobilized on soluble submicron particles
|
|
AU6267794A
(en)
|
1993-02-24 |
1994-09-14 |
Dade International Inc. |
Immobilization of specific binding assay reagents
|
|
EP0689552B1
(en)
|
1993-03-23 |
2002-10-30 |
VOROTELIAK, Victor |
A method of detecting rupture of the amniotic membranes in pregant mammals
|
|
US5431171A
(en)
|
1993-06-25 |
1995-07-11 |
The Regents Of The University Of California |
Monitoring fetal characteristics by radiotelemetric transmission
|
|
CA2170873A1
(en)
|
1993-09-03 |
1995-03-09 |
Dariush Davalian |
Fluorescent oxygen channeling immunoassays
|
|
US5650394A
(en)
|
1993-11-04 |
1997-07-22 |
Adeza Biomedical |
Use of urinastatin-like compounds to prevent premature delivery
|
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
US6140099A
(en)
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
|
US5641636A
(en)
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
|
JP3064015B2
(ja)
|
1995-01-26 |
2000-07-12 |
メルク フロスト カナダ アンド カンパニー |
プロスタグランジンレセプターｄｐ
|
|
ATE315048T1
(de)
|
1995-10-31 |
2006-02-15 |
Maruha Corp |
Monoklonaler antikoerper spezifisch fuer prostaglandin d synthetase
|
|
US6678669B2
(en)
|
1996-02-09 |
2004-01-13 |
Adeza Biomedical Corporation |
Method for selecting medical and biochemical diagnostic tests using neural network-related applications
|
|
US6120460A
(en)
|
1996-09-04 |
2000-09-19 |
Abreu; Marcio Marc |
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
|
|
US6544193B2
(en)
|
1996-09-04 |
2003-04-08 |
Marcio Marc Abreu |
Noninvasive measurement of chemical substances
|
|
FI963989L
(fi)
|
1996-10-04 |
1998-04-05 |
Wallac Oy |
Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
|
|
US6376199B1
(en)
|
1997-03-07 |
2002-04-23 |
The Hospital For Sick Children (Hsc) |
Methods to diagnose a required regulation of trophoblast invasion
|
|
US6875567B1
(en)
|
1997-11-10 |
2005-04-05 |
Genentech, Inc. |
Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis
|
|
US6610480B1
(en)
|
1997-11-10 |
2003-08-26 |
Genentech, Inc. |
Treatment and diagnosis of cardiac hypertrophy
|
|
US20020031513A1
(en)
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
|
US6267722B1
(en)
|
1998-02-03 |
2001-07-31 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6394952B1
(en)
|
1998-02-03 |
2002-05-28 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6506789B2
(en)
|
1998-06-03 |
2003-01-14 |
Shionogi & Co., Ltd. |
Methods for the treatment of itching comprising administering PGD2 receptor antagonist
|
|
US20010025140A1
(en)
|
1998-07-22 |
2001-09-27 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6149590A
(en)
|
1998-07-22 |
2000-11-21 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6126597A
(en)
|
1998-07-22 |
2000-10-03 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US7109044B1
(en)
|
1998-09-04 |
2006-09-19 |
Maruha Corporation |
Method of detection and disease state management for renal diseases
|
|
TR200101882T2
(tr)
|
1998-10-29 |
2001-12-21 |
Board Of Regents, The University Of Texas System |
Tiazolidindion türevlerinin erken doğum halinde uterus kasılmalarını veya laktasyonu önlemek için kullanımı
|
|
JP2000249709A
(ja)
|
1999-02-26 |
2000-09-14 |
Maruha Corp |
冠血管インターベンション施行後の再狭窄の予測方法
|
|
US6126616A
(en)
|
1999-06-21 |
2000-10-03 |
Sanyal; Mrinal K. |
Collection of biological products from human accessory reproductive organs by absorbent systems
|
|
JP3486408B2
(ja)
|
1999-08-23 |
2004-01-13 |
株式会社ビー・エム・エル |
物質のヒトプロスタグランジンｄ２受容体に対する性質の同定方法
|
|
FR2809182B1
(fr)
|
2000-05-18 |
2003-08-15 |
Univ Rene Descartes |
Detection de l'il-6 pour la prevision des risques d'accouchement premature
|
|
US20010053876A1
(en)
|
2000-06-15 |
2001-12-20 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
US7314727B2
(en)
|
2000-07-21 |
2008-01-01 |
Maruha Corporation |
Methods to facilitate diagnosis of normal pressure hydrocephalus
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
US20020046054A1
(en)
|
2000-08-28 |
2002-04-18 |
Morand Patrick G. |
Use of blood and plasma donor samples and data in the drug discovery process
|
|
US7217725B2
(en)
|
2000-09-14 |
2007-05-15 |
Allergan, Inc. |
Prostaglandin D2 antagonist
|
|
US20040157222A1
(en)
|
2000-10-16 |
2004-08-12 |
Alex Smolyar |
Regulation of human dendritic cell immunoreceptor
|
|
US7635571B2
(en)
|
2000-12-07 |
2009-12-22 |
Siemens Healthcare Diagnostics Products Gmbh |
Amplified signal in binding assays
|
|
ATE340796T1
(de)
|
2001-05-23 |
2006-10-15 |
Merck Frosst Canada Inc |
Dihydropyrrolo(1,2-aöindol- und tetrahydropyrido)1,2-aöindolderivate als prostaglandin rezeptor antagonisten
|
|
CA2454347A1
(en)
|
2001-07-18 |
2003-01-30 |
Merck Frosst Canada & Co./Merck Frosst Canada & Cie |
Eosinophil prostaglandin d2 receptor assays
|
|
US20040197834A1
(en)
|
2001-07-20 |
2004-10-07 |
Francois Gervais |
Method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
|
|
US20050101841A9
(en)
|
2001-12-04 |
2005-05-12 |
Kimberly-Clark Worldwide, Inc. |
Healthcare networks with biosensors
|
|
AU2003247667A1
(en)
|
2002-07-01 |
2004-01-19 |
University Of Rochester Medical Center |
Method for determination of likelihood of occurrence of preterm labor in pregnant females
|
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
|
BRPI0312818B8
(pt)
|
2002-07-19 |
2021-05-25 |
Beth Israel Deaconess Medical Ct Inc |
uso de uma medida do nível do polipeptídeo sflt-1 em uma amostra de uma paciente e uso de uma medida dos níveis de pelo menos dois dos peptídeos sflt1, vegf livre ou polipeptídio pigf livre em uma amostra de um paciente usando um métrico
|
|
DK2204654T3
(da)
|
2002-08-13 |
2013-03-11 |
N Dia Inc |
Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekretioner
|
|
WO2004021012A2
(en)
|
2002-08-29 |
2004-03-11 |
Diagnostic Technologies Ltd. |
Method of diagnosis of pregnancy-related complications
|
|
JPWO2004030674A1
(ja)
|
2002-09-30 |
2006-01-26 |
塩野義製薬株式会社 |
プロスタグランジンｄ▲下２▼、プロスタグランジンｄ▲下２▼アゴニストおよびプロスタグランジンｄ▲下２▼アンタゴニストの新規用途
|
|
WO2004037206A2
(en)
|
2002-10-23 |
2004-05-06 |
University Of Hawaii |
Methods for diagnosing and treating pre-term labor
|
|
US20040100376A1
(en)
|
2002-11-26 |
2004-05-27 |
Kimberly-Clark Worldwide, Inc. |
Healthcare monitoring system
|
|
EP1590664A4
(en)
|
2003-02-05 |
2007-05-23 |
Ciphergen Biosystems Inc |
NON-INVASIVE ASSESSMENT OF THE INTRA-NAMINE ENVIRONMENT
|
|
ATE553378T1
(de)
|
2003-02-06 |
2012-04-15 |
Hologic Inc |
Screening und behandlungsverfahren zur vorbeugung von frühgeburten
|
|
US7191068B2
(en)
|
2003-03-25 |
2007-03-13 |
Proteogenix, Inc. |
Proteomic analysis of biological fluids
|
|
US8068990B2
(en)
|
2003-03-25 |
2011-11-29 |
Hologic, Inc. |
Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
|
|
US8003765B2
(en)
|
2003-04-09 |
2011-08-23 |
Stony Brook Anaesthesiology, University Faculty Practice Corporation |
Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
|
|
US20070003992A1
(en)
|
2003-04-09 |
2007-01-04 |
Pentyala Srinivas N |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US20040203079A1
(en)
|
2003-04-09 |
2004-10-14 |
Research Foundation Of The State University Of New York |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
WO2004098389A2
(en)
|
2003-05-02 |
2004-11-18 |
Johns Hopkins University |
Devices, systems and methods for bioimpendence measurement of cervical tissue and methods for diagnosis and treatment of human cervix
|
|
EP1631547A1
(en)
|
2003-05-20 |
2006-03-08 |
Merck Frosst Canada Ltd. |
Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists
|
|
WO2005007223A2
(en)
|
2003-07-16 |
2005-01-27 |
Sasha John |
Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
|
|
JP3897117B2
(ja)
|
2003-09-24 |
2007-03-22 |
マルハ株式会社 |
妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
|
|
US20080233597A1
(en)
|
2003-09-26 |
2008-09-25 |
Yasuhiko Shiina |
Method of Detecting or Differentiating Rheumatoid Arthritis and Method of Determining Stage of Disease or Degree of Dysfunction with Regard to Rheumatoid Arthritis
|
|
US20050131287A1
(en)
|
2003-12-16 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Detection of premature rupture of the amniotic membrane
|
|
US20060024722A1
(en)
|
2004-07-30 |
2006-02-02 |
Mark Fischer-Colbrie |
Samples for detection of oncofetal fibronectin and uses thereof
|
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
|
US20080254479A1
(en)
|
2004-08-30 |
2008-10-16 |
Cervimark, Llc |
Methods and Kits For Predicting Risk For Preterm Labor
|
|
WO2006034507A2
(en)
|
2004-09-24 |
2006-03-30 |
Beth Israel - Deaconess Medical Center |
Methods of diagnosing and treating complications of pregnancy
|
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
GT200500284A
(es)
|
2004-10-15 |
2006-03-27 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
ATE519109T1
(de)
|
2004-12-21 |
2011-08-15 |
Univ Yale |
Präeklampsie-diagnose
|
|
US20060166242A1
(en)
|
2005-01-06 |
2006-07-27 |
Mount Sinai Hospital |
Markers of pre-term labor
|
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
|
CA2602963A1
(en)
*
|
2005-03-24 |
2006-09-28 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
|
US20070128589A1
(en)
|
2005-07-13 |
2007-06-07 |
Sanders Mitchell C |
Substrates, sensors, and methods for assessing conditions in females
|
|
JP5064219B2
(ja)
|
2005-07-22 |
2012-10-31 |
塩野義製薬株式会社 |
Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
|
|
EP1937709A4
(en)
|
2005-09-15 |
2011-06-08 |
Swiss Asian Property Ltd |
MARKER FOR EARLY BLEEDING (PROM)
|
|
GT200600457A
(es)
|
2005-10-13 |
2007-04-27 |
Aventis Pharma Inc |
Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
|
|
US8076315B2
(en)
|
2005-10-14 |
2011-12-13 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
|
US20070111326A1
(en)
|
2005-11-14 |
2007-05-17 |
Abbott Laboratories |
Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
|
|
US20080009552A1
(en)
|
2006-03-23 |
2008-01-10 |
Craig Pennell |
Markers of pre-term labor
|
|
AR060403A1
(es)
|
2006-04-12 |
2008-06-11 |
Sanofi Aventis |
Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
HUE030850T2
(en)
|
2006-06-16 |
2017-06-28 |
Univ Pennsylvania |
Prostaglandin D2 receptor antagonists for the treatment of hair loss
|
|
AU2007276885A1
(en)
|
2006-07-25 |
2008-01-31 |
Sanofi-Aventis |
2-phenyl-indoles as prostaglandin D2 receptor antagonists
|
|
US8133859B2
(en)
|
2006-09-27 |
2012-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
SCGB3A2 as a growth factor and anti-apoptotic agent
|
|
EP2918288B1
(en)
|
2006-10-03 |
2017-08-16 |
Genzyme Corporation |
Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
|
|
WO2008073491A1
(en)
|
2006-12-11 |
2008-06-19 |
University Of Florida Research Foundation, Inc. |
System and method for analyzing progress of labor and preterm labor
|
|
JP2010513458A
(ja)
|
2006-12-19 |
2010-04-30 |
ファイザー・プロダクツ・インク |
Ｈ−ｐｇｄｓの阻害剤としてのニコチンアミド誘導体、およびプロスタグランジンｄ２の仲介による疾患を治療するためのその使用
|
|
JP5194212B2
(ja)
|
2006-12-26 |
2013-05-08 |
ブリガム・ヤング・ユニバーシティ |
血清プロテオミクスシステムと関連する方法
|
|
CA2679198C
(en)
|
2007-02-26 |
2011-07-12 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
US20090058072A1
(en)
|
2007-08-30 |
2009-03-05 |
Shirlee Ann Weber |
Record sheets with integrated themes
|
|
US20100251394A1
(en)
|
2007-09-20 |
2010-09-30 |
The Johns Hopkins University |
Treatment and prevention of ischemic brain injury
|
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
|
WO2009061681A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc |
Antagonists of pgd2 receptors
|
|
US20130177485A1
(en)
|
2007-11-27 |
2013-07-11 |
Momtec Life Ltd. Of Yazmot Haemek |
Diagnostic device for identifying rupture of membrane during pregnancy
|
|
US20110065139A1
(en)
|
2007-11-27 |
2011-03-17 |
Jacob Mullerad |
diagnostic device for identifying rupture of membrane during pregnancy
|
|
NZ585888A
(en)
|
2007-12-14 |
2012-02-24 |
Pulmagen Therapeutics Asthma Ltd |
Indoles and their therapeutic use
|
|
US8835183B2
(en)
|
2008-01-07 |
2014-09-16 |
Ortho-Clinical Diagnostics, Inc. |
Determination of sFlt-1:angiogenic factor complex
|
|
US20110060026A1
(en)
|
2008-01-18 |
2011-03-10 |
George Hynd |
Indoles Active on CRTH2 Receptor
|
|
EP2245180B1
(en)
|
2008-01-25 |
2014-06-18 |
PerkinElmer Health Sciences, Inc. |
Methods for determining the risk of prenatal complications
|
|
WO2009097579A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
|
|
WO2009097584A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Maternal serum biomarkers for detection of pre-eclampsia
|
|
UA98839C2
(en)
|
2008-02-01 |
2012-06-25 |
Панмира Фармасьютикалз, Ллк. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
CA2713139C
(en)
|
2008-02-01 |
2013-04-23 |
Amira Pharmaceuticals, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
EP2245022A4
(en)
|
2008-02-25 |
2012-02-22 |
Panmira Pharmaceuticals Llc |
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
AU2009246116B2
(en)
|
2008-05-16 |
2013-02-14 |
Corthera, Inc. |
Method of preventing premature delivery
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
JP2011526281A
(ja)
|
2008-06-24 |
2011-10-06 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のシクロアルカン［ｂ］インドールアンタゴニスト
|
|
CA2729292C
(en)
|
2008-07-03 |
2013-09-03 |
Amira Pharmaceuticals, Inc. |
Phenoxyphenyl sulfide, sulfinyl and sulfonyl antagonists of prostaglandin d2 receptors
|
|
FR2934681B1
(fr)
|
2008-07-29 |
2011-09-30 |
Bastien Karkouche |
Dispositif pour la capture de particules biologiques et utilisation.
|
|
AU2009279809A1
(en)
|
2008-08-04 |
2010-02-11 |
Risk Assessment Labs, L.L.C. |
Multiplexed diagnostic test for preterm labor
|
|
BRPI0919004A2
(pt)
|
2008-09-22 |
2019-09-24 |
Cayman Chem Co |
composto de multiheteroarila como inibidores de h-pgds e sua utilização para o tratamento de doenças mediadas por prostaglandina d2
|
|
GB2463788B
(en)
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
GB2465062B
(en)
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
US9180114B2
(en)
|
2008-11-26 |
2015-11-10 |
President And Fellows Of Harvard College |
Neurodegenerative diseases and methods of modeling
|
|
WO2010085820A2
(en)
|
2009-01-26 |
2010-07-29 |
Amira Pharmaceuticals, Inc. |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
|
US20120046261A1
(en)
|
2009-02-27 |
2012-02-23 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing and preventing spontaneous preterm birth
|
|
GB0905964D0
(en)
|
2009-04-06 |
2009-05-20 |
King S College London |
Marker
|
|
CN102596902A
(zh)
|
2009-08-05 |
2012-07-18 |
潘米拉制药公司 |
Dp2拮抗剂及其用途
|
|
US20110090048A1
(en)
|
2009-09-29 |
2011-04-21 |
Li Conan K |
Data Transmission Device with User Identification Capability
|
|
AU2010313447A1
(en)
|
2009-10-29 |
2012-05-31 |
The Trustees Of The University Of Pennsylvania |
Method of predicting risk of preterm birth
|
|
CA2778838A1
(en)
|
2009-11-12 |
2011-05-19 |
Cervilenz Inc. |
Devices and methods for cervix measurement
|
|
ES2677944T3
(es)
|
2009-11-25 |
2018-08-07 |
Hologic Inc. |
Detección de infección intraamniótica
|
|
US20120238469A1
(en)
|
2009-12-08 |
2012-09-20 |
Cedars-Sinai Medical Center |
Diagnostic biomarker to identify women at risk for preterm delivery
|
|
US8874183B2
(en)
|
2010-02-18 |
2014-10-28 |
The Johns Hopkins University |
Preterm labor monitor
|
|
AR080590A1
(es)
|
2010-03-16 |
2012-04-18 |
Aventis Pharma Inc |
Pirimidinas sustituidas como antagonistas del receptor de la prostaglandina d2
|
|
CA2793324A1
(en)
|
2010-03-16 |
2011-09-22 |
Aventis Pharmaceuticals Inc. |
A substituted pyrimidine as a prostaglandin d2 receptor antagonist
|
|
CA2790139C
(en)
|
2010-03-22 |
2018-03-13 |
Actelion Pharmaceuticals Ltd |
3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
|
|
US20110237972A1
(en)
|
2010-03-23 |
2011-09-29 |
Robert Garfield |
Noninvasive measurement of uterine emg propagation and power spectrum frequency to predict true preterm labor and delivery
|
|
WO2011128357A2
(en)
*
|
2010-04-13 |
2011-10-20 |
Pronota N.V. |
Biomarkers for hypertensive disorders of pregnancy
|
|
EP2569253A4
(en)
*
|
2010-05-14 |
2013-10-02 |
Beth Israel Hospital |
EXTRACORPORAL DEVICES AND METHOD FOR TREATING COMPLICATIONS DURING PREGNANCY
|
|
US20110312927A1
(en)
|
2010-06-18 |
2011-12-22 |
Satish Kumar Nachaegari |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110312928A1
(en)
|
2010-06-18 |
2011-12-22 |
Lipocine Inc. |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
WO2011163554A2
(en)
|
2010-06-25 |
2011-12-29 |
Winthrop-University Hospital |
Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
|
|
TW201201805A
(en)
|
2010-07-05 |
2012-01-16 |
Actelion Pharmaceuticals Ltd |
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
|
|
AP2013006667A0
(en)
|
2010-07-12 |
2013-01-31 |
Therasyn Sensors Inc |
A device and methods for in vivo monitoring of an individual
|
|
US8765487B2
(en)
|
2010-09-01 |
2014-07-01 |
Clinical Innovations |
Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
|
|
CN103201628B
(zh)
|
2010-10-01 |
2015-09-16 |
霍罗杰克股份有限公司 |
用于诊断系统中使用的免疫测定测试条
|
|
WO2012049316A1
(en)
|
2010-10-15 |
2012-04-19 |
Olink Ab |
Dynamic range methods
|
|
CN103415769B
(zh)
|
2010-12-06 |
2017-04-12 |
迈卡蒂斯股份有限公司 |
用于妊娠性高血压疾病的生物标志物和参数
|
|
US20120196285A1
(en)
|
2011-01-31 |
2012-08-02 |
Esoterix Genetic Laboratories, Llc |
Methods for Enriching Microparticles or Nucleic Acids Using Binding Molecules
|
|
GB201101621D0
(en)
|
2011-01-31 |
2011-03-16 |
Olink Ab |
Method and product
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
JP6034394B2
(ja)
|
2011-11-09 |
2016-11-30 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
切迫妊娠高血圧腎症および／またはＨＥＬＬＰ症候群の指標としてのｓＦｌｔ−１またはエンドグリン／ＰｌＧＦ比の動態
|
|
CN104204799A
(zh)
|
2012-02-06 |
2014-12-10 |
珀金埃尔默生物信号股份有限公司 |
双受体时间分辨时间分辨荧光共振能量转移法
|
|
HK1206071A1
(en)
|
2012-05-08 |
2015-12-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for providing a preeclampsia assessment
|
|
BR112014029233A8
(pt)
|
2012-06-27 |
2019-01-29 |
Hoffmann La Roche |
método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
|
|
EP2890816B1
(en)
|
2012-08-30 |
2019-06-05 |
Ansh Labs LLC |
Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
|
|
WO2014066568A1
(en)
|
2012-10-24 |
2014-05-01 |
Winthrop-University Hospital |
Non-invasive biomarker to identify subjects at risk of preterm delivery
|
|
WO2014078622A1
(en)
*
|
2012-11-15 |
2014-05-22 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
|
EP2965088B1
(en)
*
|
2013-03-04 |
2018-12-05 |
IQ Products B.V. |
Prognostic marker to determine the risk for early-onset preeclampsia
|
|
CN105917232B
(zh)
|
2013-12-03 |
2020-10-16 |
塞尚公司 |
用于选择性确定胎盘生长因子2的方法
|
|
CN105917233B
(zh)
|
2014-01-24 |
2018-07-03 |
豪夫迈·罗氏有限公司 |
产后hellp综合征、产后子痫或产后子痫前期的预测
|
|
US10281475B2
(en)
|
2014-03-27 |
2019-05-07 |
Wayne State University |
Systems and methods to identify and treat subjects at risk for obstetrical complications
|
|
MA40325A
(fr)
|
2014-07-30 |
2016-02-04 |
Matthew Cooper |
Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie.
|
|
EP3259600B1
(en)
|
2015-02-18 |
2024-07-24 |
MirZyme Therapeutics Limited |
Diagnostic assay and treatment for preeclampsia
|
|
WO2016134324A1
(en)
|
2015-02-20 |
2016-08-25 |
Neoteryx, Llc |
Method and apparatus for acquiring blood for testing
|
|
WO2016149759A1
(en)
|
2015-03-23 |
2016-09-29 |
Adelaide Research & Innovation Pty Ltd |
Methods and systems for determining risk of a pregnancy complication occurring
|
|
EP3502705B1
(en)
|
2015-09-11 |
2020-09-09 |
Universidad de los Andes |
In vitro method for identifying a pregnancy related disease
|
|
NL2016967B1
(en)
|
2016-06-15 |
2017-12-21 |
Iq Products B V |
Markers and their ratio to determine the risk for early-onset preeclampsia.
|
|
US20190353667A1
(en)
|
2017-02-06 |
2019-11-21 |
Astute Medical, Inc. |
Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
|
|
US20190079097A1
(en)
|
2017-09-13 |
2019-03-14 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|
|
US20200264188A1
(en)
|
2017-09-13 |
2020-08-20 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|